Trial
NCT00217022
Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
AstraZeneca; National Center for Research Resources (NCRR)
Condition
Lymphocytic Colitis
Intervention
Placebo
Why stopped
Study closed early, because of low enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-02